nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achievement of Therapeutic International Normalized Ratio Following Adjustment of Tube Feeds
|
Krajewski, Kristin C. |
|
2011 |
51 |
3 |
p. 440-443 |
artikel |
2 |
Clinical Pharmacokinetics, Platelet Response, and Safety of Eltrombopag at Supratherapeutic Doses of up to 200 mg Once Daily in Healthy Volunteers
|
Matthys, Gemma |
|
2011 |
51 |
3 |
p. 301-308 |
artikel |
3 |
Effect of Diltiazem, a Moderate CYP3A Inhibitor, on the Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein Inhibitor, in Healthy Subjects
|
Garg, Amit |
|
2011 |
51 |
3 |
p. 436-439 |
artikel |
4 |
Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin
|
Whitfield, Lloyd R. |
|
2011 |
51 |
3 |
p. 378-388 |
artikel |
5 |
Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects
|
Li Zhu, |
|
2011 |
51 |
3 |
p. 368-377 |
artikel |
6 |
Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics
|
Brainard, Diana M. |
|
2011 |
51 |
3 |
p. 422-427 |
artikel |
7 |
Effects of Hepatic Dysfunction on the Single-Dose Pharmacokinetics of Fesoterodine
|
de Mey, Christian |
|
2011 |
51 |
3 |
p. 397-405 |
artikel |
8 |
Increased Oral Bioavailability of Itraconazole and Its Active Metabolite, 7-Hydroxyitraconazole, When Coadministered With a Vitamin C Beverage in Healthy Participants
|
Soo Kyung Bae, |
|
2011 |
51 |
3 |
p. 444-451 |
artikel |
9 |
Influence of Metoprolol Dosage Release Formulation on the Pharmacokinetic Drug Interaction With Paroxetine
|
Stout, Stephen M. |
|
2011 |
51 |
3 |
p. 389-396 |
artikel |
10 |
Influence of Severe Renal Impairment on the Pharmacokinetics of Clazosentan
|
Bruderer, Shirin |
|
2011 |
51 |
3 |
p. 413-421 |
artikel |
11 |
Inosine Monophosphate Dehydrogenase (IMPDH) Activity as a Pharmacodynamic Biomarker of Mycophenolic Acid Effects in Pediatric Kidney Transplant Recipients
|
Fukuda, Tsuyoshi |
|
2011 |
51 |
3 |
p. 309-320 |
artikel |
12 |
Integrated Analysis of Pharmacokinetic Data Across Multiple Clinical Pharmacology Studies of Prasugrel, a New Thienopyridine Antiplatelet Agent
|
Small, David S. |
|
2011 |
51 |
3 |
p. 321-332 |
artikel |
13 |
Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren
|
Tapaninen, Tuija |
|
2011 |
51 |
3 |
p. 359-367 |
artikel |
14 |
Pharmacokinetics of Gabapentin in a Novel Gastric-Retentive Extended-Release Formulation: Comparison With an Immediate-Release Formulation and Effect of Dose Escalation and Food
|
Cuiping Chen, |
|
2011 |
51 |
3 |
p. 346-358 |
artikel |
15 |
Pharmacokinetics of Laropiprant, a Selective Prostaglandin D2 Receptor 1 Antagonist, in Patients With Moderate Hepatic Impairment
|
Wang, Ying-Hong |
|
2011 |
51 |
3 |
p. 406-412 |
artikel |
16 |
Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years
|
Knebel, W. |
|
2011 |
51 |
3 |
p. 333-345 |
artikel |
17 |
Review: Safety of Plasma Volume Expanders
|
Farrugia, Albert |
|
2011 |
51 |
3 |
p. 292-300 |
artikel |
18 |
The In Vitro Platelet Toxicity Assay (iPTA): A Novel Approach for Assessment of Drug Hypersensitivity Syndrome
|
Elzagallaai, Abdelbaset A. |
|
2011 |
51 |
3 |
p. 428-435 |
artikel |